News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeurOp Corporation Awarded $3 Million National Institutes of Health (NIH) Grant for Ischemia Treatment Research



7/26/2011 7:23:51 AM

ATLANTA--(BUSINESS WIRE)--NeurOp, Inc., a biopharmaceutical company developing new treatments for central nervous system disorders, today announced that the National Institutes of Health (NIH) has awarded the company a $3 million grant to support its research program for ischemia. NeurOp will use the funding to advance its lead molecule to an Investigational New Drug (IND) filing for the treatment of subarachnoid hemorrhage (SAH) and those patients at risk of a stroke.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES